Moreover, emerging evidence suggests that lncRNA expression may differ across MS subtypes—some lncRNAs, such as GAS5 and MEG3, appear more consistently dysregulated in RRMS, whereas data for SPMS or PPMS remain sparse. The gene discussed is MEG3; the disease is primary progressive multiple sclerosis.